Gao, X.; Tsai, P.-C.; Chuang, K.-H.; Pai, C.-P.; Hsu, P.-K.; Li, S.-H.; Lu, H.-I.; van Lanschot, J.J.-B.; Chao, Y.-K.
Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study. Cancers 2022, 14, 2610.
https://doi.org/10.3390/cancers14112610
AMA Style
Gao X, Tsai P-C, Chuang K-H, Pai C-P, Hsu P-K, Li S-H, Lu H-I, van Lanschot JJ-B, Chao Y-K.
Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study. Cancers. 2022; 14(11):2610.
https://doi.org/10.3390/cancers14112610
Chicago/Turabian Style
Gao, Xing, Ping-Chung Tsai, Kai-Hao Chuang, Chu-Pin Pai, Po-Kuei Hsu, Shau-Hsuan Li, Hung-I Lu, Joseph Jan-Baptist van Lanschot, and Yin-Kai Chao.
2022. "Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study" Cancers 14, no. 11: 2610.
https://doi.org/10.3390/cancers14112610
APA Style
Gao, X., Tsai, P. -C., Chuang, K. -H., Pai, C. -P., Hsu, P. -K., Li, S. -H., Lu, H. -I., van Lanschot, J. J. -B., & Chao, Y. -K.
(2022). Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study. Cancers, 14(11), 2610.
https://doi.org/10.3390/cancers14112610
